Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy

By Kamiya N.   Akakura K.   Suzuki H.   Isshiki S.   Komiya A.   Ueda T.   Ito H.  

European Urology, Vol. 44, Iss. 3, 2003-09 ,pp. : 309-314

Elsevier

Access to resources Recommend Favorite

Prognostic Factors in Localised Prostate Cancer with Emphasis on the Application of Molecular Techniques

By Verhagen P.C.M.S.   Tilanus M.G.J.   de Weger R.A.   van Moorselaar R.J.A.   van den Tweel J.G.   Boon T.A.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 363-371

Elsevier

Access to resources Recommend Favorite

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet   Yiğitbası Orhan   Imamoglu Abdurrahim   Tuygun Can   Turan Celaleddin  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite

Prostate Specific Antigen: A Prognostic Marker of Survival in Good Prognosis Metastatic Prostate Cancer? (EORTC 30892)

By Collette L.   de Reijke T.M.   Schroder F.H.   Members of the EORTC Genito-Urinary Group  

European Urology, Vol. 44, Iss. 2, 2003-08 ,pp. : 182-189

Elsevier

Access to resources Recommend Favorite

Prognostic value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine therapy

By Nakashima J.   Ozu C.   Nishiyama T.   Oya M.   Ohigashi T.   Asakura H.   Tachibana M.   Murai M.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 843-847

Elsevier

Access to resources Recommend Favorite